Vistagen Therapeutics Inc (VTGN) Total Assets by Year
Vistagen Therapeutics Inc closed fiscal year 2026 with $48.6M in total assets, $13.0M in total liabilities and $35.5M in shareholder equity. This represents a decrease of 42.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Vistagen Therapeutics Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VTGN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $48.6M-42.4% | $84.3M-31.8% | $123.7M+486.3% | $21.1M-71.7% | $74.6M-31.1% | $108.3M+1775.9% | $5.8M-58.8% | $14.0M+24.2% | $11.3M+203.8% | $3.7M+275.0% | $990K+267.0% | $270K+2.3% | $264K0.0% | $264K-70.1% | $882K |
| Total Liabilities | $13.0M-6.5% | $14.0M+48.9% | $9.4M+4.0% | $9.0M-9.3% | $9.9M-39.1% | $16.3M+41.7% | $11.5M+65.8% | $6.9M+59.0% | $4.4M+40.9% | $3.1M-21.9% | $4.0M-80.9% | $20.8M+59.3% | $13.1M+1.9% | $12.8M+94.6% | $6.6M |
| Total Equity | $35.5M-49.5% | $70.4M-38.4% | $114.3M+846.1% | $12.1M-81.3% | $64.7M-29.6% | $92.0M+1705.4% | -$5.7M-181.0% | $7.1M+2.3% | $6.9M+1023.2% | $616K+120.7% | -$3.0M+85.5% | -$20.5M-60.5% | -$12.8M-1.9% | -$12.6M-120.1% | -$5.7M |
VTGN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.7M-48.2% | $48.6M-42.4% | $65.1M-29.5% | $80.9M-21.0% | $68.9M-39.3% | $84.3M-31.8% | $92.3M-29.6% | $102.5M+142.9% | $113.5M+655.4% | $123.7M+486.3% | $131.1M+341.2% | $42.2M+3.7% |
| Total Liabilities | $11.3M-7.4% | $13.0M-6.5% | $14.1M+26.4% | $14.6M+53.2% | $12.2M+39.0% | $14.0M+48.9% | $11.2M+43.7% | $9.5M+45.4% | $8.7M+6.9% | $9.4M+4.0% | $7.8M-13.8% | $6.6M-41.0% |
| Total Equity | $24.5M-56.9% | $35.5M-49.5% | $50.9M-37.2% | $66.3M-28.6% | $56.8M-45.8% | $70.4M-38.4% | $81.1M-34.2% | $93.0M+160.8% | $104.8M+1430.2% | $114.3M+846.1% | $123.3M+496.3% | $35.6M+20.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Vistagen Therapeutics Inc financials
Frequently Asked Questions
What was Vistagen Therapeutics Inc's total assets in fiscal year 2026?
Vistagen Therapeutics Inc closed fiscal year 2026 with $48.6M in total assets, $13.0M in total liabilities and $35.5M in shareholder equity.
How fast is Vistagen Therapeutics Inc's total assets growing?
Vistagen Therapeutics Inc (VTGN) total assets fell by 42.4% year over year, from $84.3M to $48.6M in fiscal year 2026.
How has Vistagen Therapeutics Inc's total assets changed over the years?
Across the 15 fiscal years this page covers, Vistagen Therapeutics Inc (VTGN) total assets went from $882K in fiscal year 2012 to $48.6M in fiscal year 2026.
What was Vistagen Therapeutics Inc's total assets in the most recent quarter?
Vistagen Therapeutics Inc (VTGN) reported $35.7M in total assets in Q1 2027. This represents a decrease of 48.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Vistagen Therapeutics Inc (VTGN) reported on that line in every period on record.